MREO
Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)
4.80 / 10
Netural
Technical analysis yields a neutral rating (4.8/10). Candlestick patterns show a long upper shadow (bullish signal) but also a long lower shadow (bearish influence), leading to conflicting signals and an overall watchful stance.
Analysis Checks(1/2)
Long Upper Shadow
Score6.39/10
Win Rate52.63%
Hist. Signals38
Avg Return2.36%
Score6.39/10
Win Rate52.63%
Hist. Signals38
Avg Return2.36%
Long Lower Shadow
Score3.22/10
Win Rate44.83%
Hist. Signals58
Avg Return2.46%
Score3.22/10
Win Rate44.83%
Hist. Signals58
Avg Return2.46%
Long Upper Shadow
Score6.39/10
Win Rate52.63%
Hist. Signals38
Avg Return2.36%
Score6.39/10
Win Rate52.63%
Hist. Signals38
Avg Return2.36%
Long Lower Shadow
Score3.22/10
Win Rate44.83%
Hist. Signals58
Avg Return2.46%
Score3.22/10
Win Rate44.83%
Hist. Signals58
Avg Return2.46%
What is the current technical signals for MREO?
- MREO presents a Netural setup with a Technical Score of 4.80/10. Key technical indicators highlight an RSI of 32.97 and a MACD of 0.07, with the trend anchored by the 50-Day SMA at 1.18. Traders should monitor key support at 0.36 and resistance at 0.41.
